Analyst Activity – Barclays PLC Reiterates Overweight on AstraZeneca plc (LON:AZN)

ME Staff
-
0

Analyst Ratings For AstraZeneca plc (LON:AZN)

Today, Barclays PLC reiterated its Overweight rating on AstraZeneca plc (LON:AZN) with a price target of GBX 6,300.

There are 3 sell ratings, 8 hold ratings, 9 buy ratings on the stock.

The current consensus rating on AstraZeneca plc (LON:AZN) is Hold (Score: 2.30) with a consensus target price of GBX 5,257.16 per share, a potential .

Some recent analyst ratings include

  • 7/26/2017-Barclays PLC Reiterated Rating of Overweight.
  • 7/21/2017-J P Morgan Chase & Co Reiterated Rating of Neutral.
  • 7/21/2017-BNP Paribas Reiterated Rating of Neutral.
  • 7/14/2017-Goldman Sachs Group, Inc. (The) Reiterated Rating of Sell.
  • 7/13/2017-Shore Capital Reiterated Rating of Hold.
  • 7/13/2017-Kepler Capital Markets Reiterated Rating of Buy.
  • 7/13/2017-Liberum Capital Reiterated Rating of Buy.


    Recent Trading Activity for AstraZeneca plc (LON:AZN)
    Shares of AstraZeneca plc closed the previous trading session at 5,116.00 up +29.00 0.57% with 1,209,708 shares trading hands.